Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-24 @ 4:14 PM
Study NCT ID:
NCT03889366
Status:
COMPLETED
Last Update Posted:
2020-02-25
First Post:
2019-03-20
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Relative Bioavailability of NXP001 Compared to Emend® in Healthy Volunteers
Sponsor:
Nuformix Technologies Limited
Organization:
Study Overview
Official Title:
Relative Bioavailability of NXP001 Compared to Emend® in Healthy Volunteers
Status:
COMPLETED
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare the relative bioavailability of both an oral capsule formulation and an oral suspension formulation of NXP001 to Emend® in healthy male volunteers in the fasted state.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: